Index Catalog // Hyrax

Filtrado por: Contributor Li, Chuan-Yuan Study Program Molecular Medicine Study Program (MolMed)

Descripción:	Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary...
Fecha de Creacion:	August 1-2, 2024

Limite su búsqueda